European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 5.00
+0.35 (7.54%)
Sep 18, 2025, 5:28 PM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €21.16 million as of September 18, 2025. Its market cap has decreased by -28.98% in one year.
Market Cap
21.16M
Enterprise Value
36.43M
Revenue
47.91M
Ranking
n/a
PE Ratio
38.75
Stock Price
€5.00
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 21.16M, a decrease of -75.42%. That is a compound annual growth rate of -13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 19.68M | -22.51% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | 4.86M | -28.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 38.57B |
| argenx SE | 38.38B |
| Financière de Tubize | 7.36B |
| Fagron NV | 1.43B |
| Ion Beam Applications | 323.69M |
| Onward Medical | 229.92M |
| Hyloris Pharmaceuticals | 170.80M |
| Nyxoah | 147.87M |